Oriheal Torsepet 2.5mg is a prescription-only, high-potency loop diuretic veterinary medication meticulously engineered for the management of severe fluid retention (edema) and congestion in dogs and cats. The active pharmaceutical ingredient, Torsemide (2.5mg), is a next-generation loop diuretic that acts primarily on the thick ascending limb of the loop of Henle. By inhibiting the Na+ / K+ / 2Cl- cotransporter system, Torsemide dramatically increases the urinary excretion of sodium, chloride, and water to quickly clear fluid collections from body tissues.

Torsemide is roughly 10 to 20 times more potent than traditional loop diuretics like furosemide and features an extended duration of action alongside superior oral bioavailability. It is frequently prescribed as a first-line or rescue therapy for companion animals suffering from advanced congestive heart failure (CHF) secondary to Myxomatous Mitral Valve Disease (MMVD) or Dilated Cardiomyopathy (DCM) that have become resistant to other diuretic protocols. In addition to its primary diuretic mechanism, Torsemide exhibits anti-aldosterone properties, which help curb structural myocardial remodeling and reduce dangerous scarring (fibrosis) in failing heart walls. Administered orally once daily, Torsepet 2.5mg effectively relieves life-threatening pulmonary edema (fluid in the lungs) and abdominal ascites, drastically reducing breathing distress, chronic coughing, and profound fatigue.